Certified professionals: CD4(+)CD25(+) suppressor T cells - PubMed (original) (raw)

Certified professionals: CD4(+)CD25(+) suppressor T cells

E M Shevach. J Exp Med. 2001.

No abstract available

PubMed Disclaimer

Similar articles

• Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
  Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Dieckmann D, et al. J Exp Med. 2001 Jun 4;193(11):1303-10. doi: 10.1084/jem.193.11.1303. J Exp Med. 2001. PMID: 11390437 Free PMC article.
• The role of regulatory T lymphocytes in asthma pathogenesis.
  Robinson DS. Robinson DS. Curr Allergy Asthma Rep. 2005 Mar;5(2):136-41. doi: 10.1007/s11882-005-0087-8. Curr Allergy Asthma Rep. 2005. PMID: 15683614 Review.
• Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
  Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Graca L, et al. J Immunol. 2002 Jun 1;168(11):5558-65. doi: 10.4049/jimmunol.168.11.5558. J Immunol. 2002. PMID: 12023351
• Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.
  Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Thornton AM, et al. J Immunol. 2004 Jun 1;172(11):6519-23. doi: 10.4049/jimmunol.172.11.6519. J Immunol. 2004. PMID: 15153463
• The role of self-peptides in the development of CD4+ CD25+ regulatory T cells.
  Picca CC, Caton AJ. Picca CC, et al. Curr Opin Immunol. 2005 Apr;17(2):131-6. doi: 10.1016/j.coi.2005.01.003. Curr Opin Immunol. 2005. PMID: 15766671 Review.

Cited by

• Immune Cell Plasticity Allows for Resetting of Phenotype From Effector to Regulator With Combined Inhibition of Notch/eIF5A Pathways.
  Imam S, Dar P, Aziz SW, Zahid ZA, Sarwar H, Karim T, Faisal S, Haseeb I, Naqvi AS, Shah R, Haque A, Salim N, Jaume JC. Imam S, et al. Front Cell Dev Biol. 2021 Nov 22;9:777805. doi: 10.3389/fcell.2021.777805. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34881246 Free PMC article.
• Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor.
  Lozano T, Casares N, Martil-Otal C, Anega B, Gorraiz M, Parker J, Ruiz M, Belsúe V, Pineda-Lucena A, Oyarzabal J, Lasarte JJ. Lozano T, et al. Biomedicines. 2021 Feb 17;9(2):197. doi: 10.3390/biomedicines9020197. Biomedicines. 2021. PMID: 33671179 Free PMC article.
• Interleukin 35 Regulatory B Cells.
  Choi JK, Egwuagu CE. Choi JK, et al. J Mol Biol. 2021 Jan 8;433(1):166607. doi: 10.1016/j.jmb.2020.07.019. Epub 2020 Aug 2. J Mol Biol. 2021. PMID: 32755620 Free PMC article. Review.
• The Role of IL-33 in Experimental Heart Transplantation.
  Chen J, He Y, Xie Z, Wei Y, Duan L. Chen J, et al. Cardiol Res Pract. 2020 Mar 19;2020:6108362. doi: 10.1155/2020/6108362. eCollection 2020. Cardiol Res Pract. 2020. PMID: 32257426 Free PMC article. Review.
• The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid.
  Erkan K, Bozkurt MK, Artaç H, Özdemir H, Ünlü A, Korucu EN, Elsürer Ç. Erkan K, et al. Eur Arch Otorhinolaryngol. 2020 Apr;277(4):1109-1114. doi: 10.1007/s00405-020-05811-4. Epub 2020 Jan 28. Eur Arch Otorhinolaryngol. 2020. PMID: 31993765

References

1. 1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995;160:1151–1164. - PubMed
2. 1. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996;184:387–396. - PMC - PubMed
3. 1. Suri-Payer E., Amar A.Z., Thornton A.M., Shevach E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998;160:1212–1218. - PubMed
4. 1. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998;188:287–296. - PMC - PubMed
5. 1. Read S., Mauze S., Asseman C., Bean A., Coffman R., Powrie F. CD38CD45RBlow T cellsa population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 1998;28:3435–3447. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program